The Decarboxylation of DOPA in the Parkinsonian Brain: In vivo Studies on an Animal Model
The site of decarboxylation of exogenously administered L-DOPA was studied in corpora striata of rats with near-total unilateral nigrostriatal lesions. After DOPA administration, the absolute increases in dopamine (DA) levels were lower in lesioned than in unlesioned striata, suggesting that, in the intact striatum, a major part of exogenous DOPA is decarboxylated in DA neurons. DOPA can also be decarboxylated outside DA neurons, however, as shown by our finding that relatively higher DOPA decarboxylase than tyrosine hydroxylase activity or DA concentration remains in striata after the nigrostriatal lesions. Also, the percentage increases in DA formation after DOPA administration were much higher in lesioned than in control striata. Rats with both raphé and nigrostriatal lesions failed to exhibit further reductions in striatal DOPA decarboxylase activity or diminished biochemical or behavioral (turning behavior) reactions to DOPA. Inhibition of the DOPA decarboxylase contained in brain capillary endothelial cells did not abolish DA formation in lesioned striata or circling behavior after DOPA administration. These findings all suggest an additional cell type in the striatum as the site of DOPA’s decarboxylation in the absence of DA neurons.
KeywordsTyrosine Hydroxylase Kainic Acid Medial Forebrain Bundle Lesion Side Brain Capillary Endothelial Cell
Unable to display preview. Download preview PDF.
- Bertler. A, Falck, B., Owman. C., Rosengren, E.: The localization of monoaminergic blood-brain barrier mechanisms. Pharmacol. Rev. 18 369–385 (1966).Google Scholar
- Neurology.Fahrt,.S, Calne, M.L: Considerations in the management of parkinsonism.Neuruology28, 5–7 (1978).Google Scholar
- Melamed, E., Hefti, F., Wurtman, R. J: Decarboxylation of L-DOPA in Parkinson’s disease. Is there a role for serotoninergic neurons? Submitted for publication.Google Scholar
- Ungerstedt, U: Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of nigrostriatal dopamine system. Acta Physiol. Scand., suppl. 367 69–93 (1971).Google Scholar
- Vogt, M: Drug-induced changes in brain dopamine and their relation to parkinsonism. Sci. Basis Med. Annu. Rev., chapter XVI, pp. 276–291 (1970).Google Scholar